Show&Tell #2: Medulloblastoma
07/10/2021
/
User Meeting
Dr Torunn Yock, Director of Pediatric Radiation Oncology, will share the main lessons...
Filter by
Filter by
Results
Filter by
Content type
Key content topics
Key audience
Top cancer treatments
Maximizing your ProteusONE experience
07/10/2021
/
User Meeting
During this event, we will share with you the release program to put in place to...
Show&Tell #3: Thoracic cancers
07/10/2021
/
User Meeting
Dr Jing Zeng, Medical Director, and Dr Alex Egan, Senior Medical Physicist, will...
2 years of Proton Therapy experience at Apollo
07/06/2021
/
Webinar
/
Proton therapy center
Dr Rakesh Jalali showcases the Apollo Proton Cancer Center in Chennai, India.
IBA Symposium on ConformalFLASH® - ASTRO Congress - 24 to 27 October 2021
03/10/2021
/
Event
We are delighted to invite you to our in-person flash symposium taking place in...
Future technological developments in proton therapy - A predicted technological breakthrough
08/07/2021
/
Publications
/
ARC therapy
Pencil Beam Scanning - PBS
FLASH Therapy
This article presents an overview of on-going technical developments and innovations that the authors felt most important today, as well as those that have the...
Proton Therapy Clinical Education Program Introduction (Teaser)
04/10/2021
/
Training
/
training
Internship
Certification
Hands-on
The Proton Therapy Clinical Education Program is a comprehensive training course covering the clinical practice and application of proton therapy. This training...
Proton Therapy Clinical Education Program Introduction (module 1)
03/10/2021
/
Training
/
Hands-on
Certification
Internship
training
The Proton Therapy Clinical Education Program is a comprehensive training course covering the clinical practice and application of proton therapy. This training...
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience A
08/06/2021
/
Publications
/
Reirradiation
Survival
Toxicity
A study by the MD Anderson group evaluated the outcomes of 573 patients treated at the institute. Oropharynx (33.3%; n = 191), paranasal sinus (11%; n = 63)...